Product NDC: | 0085-1402 |
Proprietary Name: | Foradil |
Non Proprietary Name: | formoterol fumarate |
Active Ingredient(s): | 12 ug/1 & nbsp; formoterol fumarate |
Administration Route(s): | RESPIRATORY (INHALATION) |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0085-1402 |
Labeler Name: | Merck Sharp & Dohme Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020831 |
Marketing Category: | NDA |
Start Marketing Date: | 20010216 |
Package NDC: | 0085-1402-01 |
Package Description: | 12 BLISTER PACK in 1 BOX, UNIT-DOSE (0085-1402-01) > 1 CAPSULE in 1 BLISTER PACK (0085-1402-02) |
NDC Code | 0085-1402-01 |
Proprietary Name | Foradil |
Package Description | 12 BLISTER PACK in 1 BOX, UNIT-DOSE (0085-1402-01) > 1 CAPSULE in 1 BLISTER PACK (0085-1402-02) |
Product NDC | 0085-1402 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | formoterol fumarate |
Dosage Form Name | CAPSULE |
Route Name | RESPIRATORY (INHALATION) |
Start Marketing Date | 20010216 |
Marketing Category Name | NDA |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | FORMOTEROL FUMARATE |
Strength Number | 12 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |